Otic Pharma Report issue

For profit Phase 2
Founded: Irvine CA United States (2008)
Status: Acquired by Novus Pharma (2017)

Organization Overview

First Clinical Trial
2009
NCT00872209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

ciprofloxacin (cipro) (3 trials)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ear Diseases (Phase 2)

Otitis (Phase 2)

Otitis Externa (Phase 2)

Otorhinolaryngologic Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2